The current status of sweat testing for drugs of abuse: A review

Current Medicinal Chemistry

Volumn 20, Issue 4, 2013, Pages 545-561

  De Giovanni, N ^a   Fucci, N ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Drugs of abuse; Sweat testing; Unconventional matrix

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; ATOMOXETINE; BUPRENORPHINE; CANNABIS; COCAINE; CODEINE; METHADONE; METHYLPHENIDATE; OPIATE; SUNITINIB; XENOBIOTIC AGENT;

ATTENTION DEFICIT DISORDER; CORE TEMPERATURE; DRUG ABUSE; DRUG EXCRETION; DRUG MONITORING; DRUG SCREENING; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORENSIC TOXICOLOGY; GASTROINTESTINAL TUMOR; HEAT LOSS; HUMAN; KIDNEY CARCINOMA; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PAIN; PANCREATIC NEUROENDOCRINE TUMOR; RADIOIMMUNOASSAY; REVIEW; SOLID PHASE MICROEXTRACTION; SWEAT; SWEAT TEST; SWEATING; TANDEM MASS SPECTROMETRY; TRANSDERMAL PATCH;

EID: 84877939052     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986713804910139     Document Type: Review

References (115)

1. Hardman J.G.; Limbird L.E.; Molinoff P.B.; Ruddon R.W.; Goodman Gilman A.; Goodman & Gilman: Le basi farmacologiche della terapia. McGraw-Hill Ed. Milano, Italy.
2. Cone, E.J.; Hillsgrove, M.J.; Jenkins, A.J.; Keenan, R.M.; Darwin, W.D. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol. 1994, 18, 298-305. (Pubitemid 24294667)
3. Smith, F.P.; Kidwell, D.A. Cocaine in hair, saliva skin swabs and urine of cocaine users' children. Forensic Sci. Int. 1996, 83, 179-189. (Pubitemid 27042183)
4. Kidwell, D.A.; Blanco, M.A.; Smith, F.P. Cocaine detection in a university population by hair analysis and skin swab testing. Forensic Sci. Int. 1997, 84, 75-86. (Pubitemid 27055626)
5. de Oliveira, C.D.R.; Roehsig, M.; de Almeida, R.M.; Rocha, W.L.; Yonamine, M. Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Current Pharmaceutical Analysis 2007, 3(2), 95-109. (Pubitemid 46773902)
6. Bush, D.M. The US mandatory guidelines for federal workplace drug testing programs: current status and future considerations Forensic Sci. Int. 2008, 174, 111-119.
7. Vearrier, D.; Curtis, J.A.; Greenberg, M.I. Biological testing for drugs of abuse. EXS 2010, 100, 489-517.
8. Cone, E.J. New developments in biological measures of drug prevalence. NIDA Res Monogr. 1997,167, 108-29.
9. Kintz, P. Drug testing in addicts: a comparison between urine, sweat, and hair. Ther. Drug Monit. 1996, 18, 450-5. (Pubitemid 26264666)
10. Phillips, M. An Improved Adhesive Patch for Long-Term Collection of Sweat. Biomat. Med. Dev. Art. Org. 1980, 8(1), 13-21. (Pubitemid 10064129)
11. Huestis, M.A.; Oyler, J.M.; Cone, E.J.; Wstadik, A.T.; Schoendorfer, D.; Joseph, R.E. Jr. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed Sci. Appl. 1999, 733, 247-64. (Pubitemid 29481775)
12. Kintz, P.; Brenneisen, R.; Bundeli, P.; Mangin, P. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin Chem. 1997, 43(5), 736-9. (Pubitemid 27208774)
13. Kidwell, D.A.; Smith, F.P. Susceptibility of PharmChek drugs of abuse patch to environmental contamination. Forensic Sci. Int. 2001,116 (2-3), 89-106. (Pubitemid 32141013)
14. Caplan, Y.H.; Gooldberger, B.A. Alternative specimens for Workplace Drug Testing. J. Anal. Toxicol. 2001, 25, 396-9. (Pubitemid 32660387)
15. Inoue, T.; Seta, S. Analysis of Drugs in Unconventional Samples. For. Sci. Rev. 1992,4,89-107.
16. Kidwell, D.A.; Holland, J.C.; Athanaselis, S. Testing for drugs of abuse in saliva and sweat-review. J. Chromatogr. 1998, 713, 111-135. (Pubitemid 28346482)
17. Skopp, G.; Pötsch, L. Perspiration versus saliva-basic aspects concerning their use in roadside drug testing.. Int. J. Legal Med. 1999, 112(4), 213-21. (Pubitemid 29319109)
18. Cone, E.J. Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale. For. Sci. Int. 2001, 121(1-2)7-15. (Pubitemid 32758807)
19. Dolan, K.; Rouen, D.; Kimber, J. An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev. 2004, 23(2), 213-7. (Pubitemid 38907026)
20. Maurer, H.H. Analytical Toxicology. EXS. 2010, 100, 317-37.
21. Shearer, D.S.; Baciewicz, G.J.; Kwong, T.C. Drugs of abuse testing in a psychiatric outpatient service. Clin. Lab. Med. 1998, 18(4),713-26. (Pubitemid 28531298)
22. DuPont, R. L. Drug testing in clinical settings. Journal of Global Drug Policy and Practice, 2010, 3(4).
23. Randall W.C.; American J. Phys. Med.1953, 32, 292.
24. Eichna L.W.; Bean W.B.; Ashe W.F.; Nelson N. Bull. Johns Hopkins Hosp. 1945, 76, 25.
25. Levisky, J.A.; Bowerman, D.L.; Jenkins, W.W.; Karch, S.B. Drug deposition in adipose tissue and skin: evidence for an alternative source of positive sweat patch tests. Forensic Sci. Int. 2000, 110(1), 35-46. (Pubitemid 30232769)
26. Chawarski, M.C.; Fiellin, D.A.; O. Connor, P.G.; Bernard, M.; Schottenfeld, R.S. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. J. Subst. Abuse Treat. 2007, 33(4),411-5. (Pubitemid 350030396)
27. Brunet, B.R.; Barnes, A.J.; Choo, R.E.; Mura, P.; Jones, H.E.; Huestis, M.A. Monitoring pregnant women. illicit opiate and cocaine use with sweat testing. Ther. Drug Monit. 2010, 32(1), 40-9.
28. Huestis M.A.; Cone, E.J. Alternative testing matrices in Karch SB. Drug abuse Handbook Boca Raton CRC Press 1998.
29. Inaba T. Cocaine: pharmacokinetics and biotransformation in man. Can. J. Physiol. Pharmacol. 1989, 67(9), 1154-7. Review. (Pubitemid 20002378)
30. Kacinko, S.L.; Barnes, A.J; Schwilke, E.W.; Cone, E.J.; Moolchan, E.T.; Huestis, M.A. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin. Chem. 2005, 51(11), 2085-94. (Pubitemid 41532624)
31. Uemura, N.; Nath, R.P.; Harkey, M.R.; Henderson, G.L.; Mendelson, J.; Jones, R.T. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J. Anal. Toxicol. 2004, 28(4), 253-9. (Pubitemid 38581579)
32. Schwilke, E.W.; Barnes, A.J.; Kacinko, S.L.; Cone, E.J.; Moolchan, E.T.; Huestis, M.A. Opioid disposition in human sweat after controlled oral codeine administration. Clin. Chem. 2006, 52(8),1539-45. (Pubitemid 44148317)
33. Walter K.; Kurz H. Binding of drugs to human skin: influencing factors and the role of tissue lipids. J. Pharm. Pharmacol. 1988, 40, 689-93.
34. Faergermann J.; Zehender H.; Denouel J.; Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum) sebum, hair, and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm. Venereol. 1993, 73, 305-9. (Pubitemid 23282980)
35. Burns M.; Baselt R.C. Monitoring drug use with a sweat patch: an experiment with cocaine.J. Anal.Toxicol. 1985, 19, 41-48.
36. Joseph, R.E. Jr.; Oyler, J.M.; Wstadik, A.T.; Ohuoha, C.; Cone, E.J. Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum. J. Anal. Toxicol. 1998, 22(1), 6-17. (Pubitemid 28110239)
37. Liberty, H.J.; Johnson, B.D.; Fortner, N. Detecting cocaine use through sweat testing: multilevel modeling of sweat patch length-of-wear data. J. Anal. Toxicol. 2004, 28(8), 667-73. (Pubitemid 39489041)
38. Kidwell, D.A.; Kidwell, J.D.; Shinohara, F.; Harper, C.; Roarty, K.; Bernadt, K.; McCaulley, R.A.; Smith, F.P. Comparison of daily urine, sweat, and skin swabs among cocaine users. Forensic Sci. Int. 2003, 133(1-2), 63-78. (Pubitemid 36559585)
39. Pichini, S.; Navarro, M.; Pacifici, R.; Zuccaro, P.; Ortuno, J.; Farré, M.; Roset, P.N.; Segura, J. ; de la Torre, R. Usefulness of sweat testing for the detection of MDMA after a single-dose administration. J. Anal. Toxicol. 2003, 27(5), 294-303. (Pubitemid 36877173)
40. Balabanova, S.; Schneider, E.; Wepler, R.; Hermann, B.; Boschek, H.J.; Scheitler, H. Significance of drug determination in pilocarpine sweat for detection of past drug abuse. Beitr. Gerichtl Med. 1992, 50,111-5. (Pubitemid 23030098)
41. Cole, D.E.; Boucher, M.J. Use of a new sample-collection device (Macroduct) in anion analysis of human sweat. Clin. Chem. 1986, 32(7), 1375-8. (Pubitemid 17020840)
42. Spiehler, V.; Fay, J.; Fogerson, R.; Schoendorfer, D.; Niedbala, R.S. Enzyme immunoassay validation for qualitative detection of cocaine in sweat. Clin. Chem. 1996, 42(1), 34-8. (Pubitemid 26030379)
43. Burns, M.; Baselt, R.C. Monitoring drug use with a sweat patch: an experiment with cocaine. J. Anal. Toxicol. 1995, 19(1), 41-8.
44. Skopp, G.; Pötsch, L.; Eser, H.P.; Möller, M.R. Preliminary practical findings on drug monitoring by a transcutaneous collection device. J. Forensic Sci. 1996, 41(6), 933-7. (Pubitemid 26377872)
45. Kintz, P.; Tracqui, A.; Mangin, P. Sweat testing for benzodiazepines. J. Forensic Sci. 1996, 41(5), 851-4. (Pubitemid 26307000)
46. Kintz, P.; Tracqui, A.; Jamey, C.; Mangin, P. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J. Anal. Toxicol. 1996, 20(3), 197-201. (Pubitemid 26143949)
47. Liberty, H.J.; Johnson, B.D.; Fortner, N.; Randolph, D. Detecting crack and other cocaine use with fastpatches. Addict Biol. 2003, 8(2), 191-200. (Pubitemid 36859660)
48. Fogerson, R.; Schoendorfer, D.; Fay, J.; Spiehler, V. Qualitative detection of opiates in sweat by EIA and GC-MS. J. Anal. Toxicol. 1997, 21(6), 451-8. (Pubitemid 27413690)
49. Balabanova, S.; Schneider, E. Detection of drugs in sweat. Beitr. Gerichtl Med. 1990, 48, 45-9.
50. Moody, D.E.; Cheever, M.L. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches. J. Anal. Toxicol. 2001, 25(3), 190-7. (Pubitemid 32294886)
51. Moody, D.E.; Spanbauer, A.C.; Taccogno, J.L.; Smith, E.K. Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry. J. Anal. Toxicol. 2004, 28(2), 86-93. (Pubitemid 38352322)
52. Mura, P.; Kintz, P.; Papet, Y.; Ruesch, G.; Piriou, A. Evaluation of six rapid tests for screening of cannabis in sweat, saliva and tears. Acta Clin Belg Suppl. 1999, 1, 35-8. (Pubitemid 29165554)
53. Samyn, N.; Van Haeren, C. On-site testing of saliva and sweat with drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. International Journal of Legal Medicine, 2000,113(3), 150-154. (Pubitemid 30339652)
54. Pacifici, R.; Farré, M.; Pichini, S.; Ortuno, J.; Roset, P.N.; Zuccaro, P.; Segura, J.; de la Torre, R. Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers. J. Anal. Toxicol. 2001, 25 (2),144-6. (Pubitemid 32205331)
55. Hazarika, P.; Jickells, S.M.; Wolff, K.; Russell, D.A. Multiplexed detection of metabolites of narcotic drugs from a single latent fingermark. Anal. Chem. 2010, 82 (22), 9150-4.
56. Henderson, G.L.; Wilson, B.K. Excretion of methadone and metabolites in human sweat. Res. Commun. Chem. Pathol. Pharmacol. 1973, 5 (1), 1-8.
57. Fay,J.; Fogerson, R.; Schoendorfer, D.; Niedbala, R.S.; Spiehler, V. Detection of methamphetamine in sweat by EIA and GC-MS. J. Anal. Toxicol. 1996, 20 (6), 398-403. (Pubitemid 26327461)
58. Maurer, H.H.; Arlt, J.W.; Kraemer, T.; Schmitt, C.J.; Weber, A.A. Analytical development for low molecular weight xenobiotic compounds. Arch. Toxicol. Suppl. 1997, 19, 189-97.
59. Segura, J.; Ventura, R.; Jurado, C. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J. Chromatogr. B Biomed. Sci. Appl. 1998, 21,713(1),61-90. (Pubitemid 28346480)
60. Kintz, P.; Henrich, A.; Cirimele, V.; Ludes, B. Nicotine monitoring in sweat with a sweat patch. J. Chromatogr. B Biomed. Sci. Appl. 1998,705 (2), 357-61. (Pubitemid 28082990)
61. Preston, K.L.; Huestis, M.A.; Wong, C.J.; Umbricht, A.; Goldberger, B.A.; Cone, E.J. Monitoring cocaine use in substance-Abuse-treatment patients by sweat and urine testing. J. Anal. Toxicol. 1999, 23 (5),313-22. (Pubitemid 29418297)
62. Huestis, M.A.; Cone, E.J.; Wong, C.J.; Umbricht, A.; Preston, K.L. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J. Anal. Toxicol. 2000, 24 (7),509-21.
63. Kintz, P.; Villain, M.; Cirimele, V.; Goullé, J.P.; Ludes, B. Crime under the influence of psychoactive drugs: the problem of the duration of detection. Acta Clin. Belg. Suppl. 2002 (1), 24-30.
64. Samyn, N.; De Boeck, G.; Verstraete, A.G. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci. 2002, 47(6),1380-7. (Pubitemid 35304218)
65. Saito, T.; Wtsadik, A.; Scheidweiler, K.B.; Fortner, N.; Takeichi, S.; Huestis, M.A. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin. Chem. 2004, 50 (11), 2083-90. (Pubitemid 39425846)
66. Follador, M.J.; Yonamine, M.; de Moraes Moreau, R.L.; Silva, O.A. Detection of cocaine and cocaethylene in sweat by solid-phase microextraction and gas chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 811(1) 37-40. (Pubitemid 39348846)
67. Pichini, S.; Abanades, S.; Farré, M.; Pellegrini, M.; Marchei, E.; Pacifici, R.; de la Torre, L.; Zuccaro, P. Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. Rapid Commun. Mass Spectrom. 2005, 19 (12),1649-56. (Pubitemid 40831946)
68. Yang W.; Varnes A.J.; Ripple M.G.; Fowlere D.R.; Cone EJ; Moolchan E.T.; Chung H.; Huestis MA Simultaneuos quantification of metanfetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography -mass spectrometry. J. Chromatogr. 2006, 833, 210-8.
69. Abanades, S.; Farré, M.; Segura, M.; Pichini, S.; Pastor, A.; Pacifici, R.; Pellegrini, M.; de la Torre, R. Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring. Ther. Drug. Monit. 2007, 29(1),64-70. (Pubitemid 46279878)
70. De Martinis, B.S.; Barnes, A.J.; Scheidweiler, K.B.; Huestis, M.A. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852(1-2), 450-8. (Pubitemid 46830153)
71. Brunet, B.R.; Barnes, A.J.; Scheidweiler, K.B.; Mura, P.; Huestis, M.A. Development and validation of a solid-phase extraction gas chromatographymass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal. Bioanal. Chem. 2008, 392(1-2), 115-27.
72. Fucci, N.; De Giovanni, N.; Scarlata, S. Sweat testing in addicts under methadone treatment: An italian experience. Forensic Sci. Int. 2008 174 (2-3), 107-110.
73. Barnes, A.J.; De Martinis, B.S.; Gorelick, D.A.; Goodwin, R.S.; Kolbrich, E.A.; Huestis, M.A. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clin. Chem. 2009, 55(3),454-62.
74. Barnes, A.J.; Brunet, B.R.; Choo, R.E.; Mura, P.; Johnson, R.E.; Jones, H.E.; Huestis, M.A. Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther. Drug. Monit. 2010, 32(4),497-503.
75. Concheiro, M.; Shakleya, D.M.; Huestis, M.A. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 2011, 400 (1), 69-78.
76. Marchei, E.; Farré, M.; Pardo, R.; Garcia-Algar, O.; Pellegrini, M.; Pacifici, R.; Pichini, S. Usefulness of sweat testing for the detection of methylphenidate after fast-And extended-release drug administration: a pilot study. Ther. Drug. Monit. 2010, 32(4),508-11.
77. Cirimele, V.; Kintz, P.; Gosselin, O.; Ludes, B. Clozapine doseconcentration relationships in plasma, hair and sweat specimens of schizo phrenic patients. For. Sci. Int. 2000,107(1-3),289-300. (Pubitemid 30019300)
78. Al-Dirbashi, O.Y.; Ikeda, K.; Takahashi, M.; Kuroda, N.; Ikeda, S.; Nakashima, K. Drugs of abuse in a non-conventional sample; detection of methamphetamine and its main metabolite, amphetamine in abusers. clothes by HPLC with UV and fluorescence detection. Biomed. Chromatogr. 2001, 15(7), 457-63. (Pubitemid 33064796)
79. Crouch, D.J.; Cook, R.F.; Trudeau, J.V.; Dove, D.C.; Robinson, J.J.; Webster, H.L.; Fatah, A.A. The detection of drugs of abuse in liquid perspiration. J. Anal. Toxicol. 2001, 25(7), 625-7. (Pubitemid 32939070)
80. Kintz, P.; Tracqui, A.; Marzullo, C.; Darreye, A.; Tremeau, F.; Greth, P.; Ludes, B. Enantioselective analysis of methadone in sweat as monitored by liquid chromatography/ion spray-mass spectrometry. Ther. Drug. Monit. 1998, 20 (1), 35-40. (Pubitemid 28110099)
81. Samyn, N.; De Boeck, G.; Wood, M.; Lamers, C.T.; De Waard, D.; Brookhuis, K.A.; Verstraete, A.G.; Riedel, W.J. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. For. Sci.Int. 2002, 128 (1-2), 90-7.
82. Gallardo, E.; Barroso, M.; Queiroz, J.A. LC-MS: a powerful tool in workplace drug testing. Drug Test. Anal. 2009, 3, 109-15.
83. Marchei, E.; Papaseit, E.; Garcia-Algar, O.Q.; Farré, M.; Pacifici, R.; Pichini, S. Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2012, 60, 26-31.
84. Kintz, P.; Tracqui, A.; Mangin, P.; Edel, Y. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 1996, 20 (6), 393-7. (Pubitemid 26327460)
85. Taylor, J.R.; Watson, I.D.; Tames, F.J.; Lowe, D. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing. Addiction. 1998, 93 (6), 847-53. (Pubitemid 28287072)
86. Levisky, J.A.; Bowerman, D.L.; Jenkins, W.W.; Johnson, D.G.; Levisky, J.S.; Karch, S.B. Comparison of urine to sweat patch test results in court ordered testing. For. Sci. Int. 2001, 122(1), 65-8. (Pubitemid 32918227)
87. de la Torre, R.; Farré, M.; Navarro, M.; Pacifici, R.; Zuccaro, P.; Pichini, S. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin. Pharmacokinet. 2004,43(3),157-85. (Pubitemid 38294379)
88. Suzuki,S.; Inoue, T.; Hori, H.; Inayama, S. Analysis of methamphetamine in hair, nail, sweat, and saliva by mass fragmentography. J. Anal. Toxicol. 1989, 13(3),176-8. (Pubitemid 19143563)
89. Barnes, A.J.; Smith, M.L.; Kacinko, S.L.; Schwilke, E.W.; Cone, E.J.; Moolchan, E.T.; Huestis, M.A. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.. Clin Chem. 2008, 54(1),172-80. (Pubitemid 351182611)
90. Kintz, P. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration. J. Anal. Toxicol. 1997, 21(7),570-5. (Pubitemid 27518000)
91. Kintz, P.; Samyn, N. Determination of "Ecstasy" components in alternative biological specimens. J. Chromatogr. B Biomed. Sci. Appl. 1999, 733 (1-2),137-43. (Pubitemid 29481770)
92. De Martinis, B.S. Sweat as an alternative matrix for amphetamines and methylenedioxy derivatives analysis. Current Pharmaceutical Analysis 2008, 4(4), 274-278.
93. de la Torre, R.; Pichini, S. Usefulness of sweat testing for the detection of cannabis smoke. Clin. Chem. 2004, 50(11), 1961-2. (Pubitemid 39425826)
94. Johansson, E.; Norén, K.; Sjövall, J.; Halldin, M.M. Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry. Biomed. Chromatogr. 1989, 3(1), 35-38. (Pubitemid 19036470)
95. Staub, C. Chromatographic procedures for determination of cannabinoids in biological samples with special attention to blood and alternative matrices like hair, saliva, sweat and meconium. J. Chromatogr. B 733, 1999, 119-126. (Pubitemid 29481768)
96. Kintz, P.; Cirimele, V.; Ludes, B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J. Anal. Toxicol. 2000, 24(7), 557-61.
97. Huestis, M.A.; Scheidweiler, K.B.; Saito, T.; Fortner, N.; Abraham, T.; Gustafson, R.A.; Smith, M.L. Excretion of Delta9-tetrahydrocannabinol in sweat. For. Sci. Int. 2008, 174 (2-3),173-7.
98. Winhusen, T.M.; Somoza, E.C.; Singal, B.; Kim, S.; Horn, P.S.; Rotrosen, J. Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report. Addiction 2003 98 (3), 317-24. (Pubitemid 36269570)
99. Kintz, P.; Cirimele, V.; Ludes, B. Codeine testing in sweat and saliva with the Drugwipe. Int. J. Legal Med. 1998, 111(2), 82-4. (Pubitemid 28077802)
100. Balabanova, S.; Schneider, E.; Bühler, G.; Krause, H. Presence of methadone in apocrine sweat of the human. Z. Rechtsmed. 1990, 103 (5)323-7.
101. Concheiro, M.; Jones, H.E.; Johnson, R.E.; Choo, R.; Huestis, M.A. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther. Drug Monit. 2011, 33(5), 619-26.
102. Balabanova, S.; Krupienski, M. Detection of nicotine in eccrine sweat after stimulation of sweat glands during nicotine withdrawal. Hautarzt. 1995, 46(4), 255-8.
103. Ishiyama,I.; Nagai, T.; Nagai, T.; Komuro, E.; Momose, T.; Akimori, N.The significance of drug analysis of sweat in respect to rapid screening for drug abuse. Z. Rechtsmed. 1979, 8, 82(4), 251-6. (Pubitemid 9136744)
104. Marchei, E.; Farré, M.; Pellegrini, M.; Garcia-Algar O.; Vall O.; Pacifici, R., Pichini, S. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject. Forensic Sci. Int. 2010, 196(1-3), 59-63.
105. Lankheet, N.A.G. ;Blank, C.U.; Mallo, H.; Adriaansz, S. ;Rosing, H.; Schellens, J.H.M.; Huitema, A.D.R.; Beijnen, J.H. Determination of sunitinib and its active methabolite N-desethylsunitinib in sweat of a patient. J.Anal.Toxicol. 35, 2011, 558-565.
106. Verstraete, A.; Puddu, M. Evaluation of different roadsite drug tests -Bruxelles: European Commition 2000 (Project Profile: ROSITA).
107. Samyn, N.; Verstraete, A. On-site testing for drugs of abuse in urine, saliva and sweat. Vor-ort-tests zur drogenerkennung in urin, speichel und schweiss. Blutalkohol 2000, 37(2), 58-69. (Pubitemid 30196039)
108. Kintz, P.; Cirimele, V.; Mairot, F.; Muhlmann, M.; Ludes, B. Drug tests on 198 drivers involved in an accident. Presse Med. 2000, 29(23) 1275-8. (Pubitemid 30451187)
109. Walsh, J.M.; de Gier, J.J.; Christopherson, A.S.; Verstraete, A.G. Drugs and driving. Traffic Inj. Prev. 2004 (3) 241-53. (Pubitemid 39049928)
110. Rivier, L. Techniques for analytical testing of unconventional samples. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 2000, 14(1),147-65. (Pubitemid 30487656)
111. Rivier, L. Analytical testing for sporting doping on alternative biological samples. Biology of sport, 2000, ,17, 87-106.
112. Huestis, M.A.; Choo, R.E. Drug abuse. smallest victims: in utero drug exposure. Forensic Sci. Int. 2002, 128(1-2), 20-30.
113. Lozano, J.; García-Algar, O.; Vall, O.; de la Torre, R.; Scaravelli, G. Pichini, S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007, 29(6),711-34. (Pubitemid 350190848)
114. Gray, T.; Huestis, M. Bioanalytical procedures for monitoring in utero drug exposure. Anal. Bioanal. Chem. 2007 388(7),1455-65. (Pubitemid 47150872)
115. Daughton, C.G. Illicit drugs: contaminants in the environment and utility in forensic epidemiology. Rev. Environ. Contam. Toxicol. 2011, 210, 59-110.